Microbiology of diabetic foot infections : role of ertapenem
Copyright 2013 Prous Science, S.A.U. or its licensors. All rights reserved..
Many patients with diabetes develop foot ulcers that are very susceptible to infections which may place the patients at risk for lower-limb amputation. Such infections require adequate management with antibiotics. The authors performed a systematic analysis and critical review of studies with the dual aim of assessing bacterial profiles and antimicrobial susceptibility patterns in patients with diabetic foot infections using various methods for sample collection and evaluating the safety and efficacy of ertapenem as initial empirical treatment for such infections. Following a selection of only studies with adequate description of methods for pathogen isolation and antibiogram determination, nine studies were included. The need for adequate prospective multicenter studies to assess the value of empirical antibiotic regimens for diabetic foot became evident and the conclusions were as follows: proper identification of causative agents, appropriate antibiotic therapy and management of complications in these infections are essential to achieve a successful outcome; the sampling procedure is extremely important in the evaluation of the microbial flora of the foot ulcer; susceptibility testing should be performed routinely at least for those species with unpredictable resistance; and ertapenem has been shown to be useful in the treatment of a wide range of moderate-to-severe lower extremity infections in a broad spectrum of patients.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2013 |
|---|---|
| Erschienen: |
2013 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:49 Suppl A |
|---|---|
| Enthalten in: |
Drugs of today (Barcelona, Spain : 1998) - 49 Suppl A(2013) vom: 10. Mai, Seite 1-20 |
| Sprache: |
Portugiesisch |
|---|
| Weiterer Titel: |
Microbiologia das infecções no pé diabético: o papel do ertapenem |
|---|
| Beteiligte Personen: |
Lima, A L L M [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Anti-Bacterial Agents |
|---|
| Anmerkungen: |
Date Completed 15.08.2013 Date Revised 02.12.2018 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1358/dot.2013.49(Suppl.A).1981340 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM227947983 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM227947983 | ||
| 003 | DE-627 | ||
| 005 | 20231224074813.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2013 xx |||||o 00| ||por c | ||
| 024 | 7 | |a 10.1358/dot.2013.49(Suppl.A).1981340 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0759.xml |
| 035 | |a (DE-627)NLM227947983 | ||
| 035 | |a (NLM)23724414 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a por | ||
| 100 | 1 | |a Lima, A L L M |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Microbiology of diabetic foot infections |b role of ertapenem |
| 246 | 3 | 3 | |a Microbiologia das infecções no pé diabético: o papel do ertapenem |
| 264 | 1 | |c 2013 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 15.08.2013 | ||
| 500 | |a Date Revised 02.12.2018 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright 2013 Prous Science, S.A.U. or its licensors. All rights reserved. | ||
| 520 | |a Many patients with diabetes develop foot ulcers that are very susceptible to infections which may place the patients at risk for lower-limb amputation. Such infections require adequate management with antibiotics. The authors performed a systematic analysis and critical review of studies with the dual aim of assessing bacterial profiles and antimicrobial susceptibility patterns in patients with diabetic foot infections using various methods for sample collection and evaluating the safety and efficacy of ertapenem as initial empirical treatment for such infections. Following a selection of only studies with adequate description of methods for pathogen isolation and antibiogram determination, nine studies were included. The need for adequate prospective multicenter studies to assess the value of empirical antibiotic regimens for diabetic foot became evident and the conclusions were as follows: proper identification of causative agents, appropriate antibiotic therapy and management of complications in these infections are essential to achieve a successful outcome; the sampling procedure is extremely important in the evaluation of the microbial flora of the foot ulcer; susceptibility testing should be performed routinely at least for those species with unpredictable resistance; and ertapenem has been shown to be useful in the treatment of a wide range of moderate-to-severe lower extremity infections in a broad spectrum of patients | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Antibiotic therapy | |
| 650 | 4 | |a Diabetes | |
| 650 | 4 | |a Diabetic foot infections | |
| 650 | 4 | |a Ertapenem | |
| 650 | 4 | |a Susceptibility testing | |
| 650 | 7 | |a Anti-Bacterial Agents |2 NLM | |
| 650 | 7 | |a beta-Lactams |2 NLM | |
| 650 | 7 | |a Ertapenem |2 NLM | |
| 650 | 7 | |a G32F6EID2H |2 NLM | |
| 700 | 1 | |a Oliveira, P R |e verfasserin |4 aut | |
| 700 | 1 | |a Carvalho, V C |e verfasserin |4 aut | |
| 700 | 1 | |a Peixoto de Miranda, E J |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Drugs of today (Barcelona, Spain : 1998) |d 1998 |g 49 Suppl A(2013) vom: 10. Mai, Seite 1-20 |w (DE-627)NLM123139600 |x 1699-3993 |7 nnns |
| 773 | 1 | 8 | |g volume:49 Suppl A |g year:2013 |g day:10 |g month:05 |g pages:1-20 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1358/dot.2013.49(Suppl.A).1981340 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 49 Suppl A |j 2013 |b 10 |c 05 |h 1-20 | ||